ArticleDrug design, development and therapy2025

Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study.

Guohui Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.